Navigation Links
The Olive Branch Fund Announces Funding Award to Harvard Researcher
Date:6/29/2011

NASHVILLE, Tenn., June 29, 2011 /PRNewswire-USNewswire/ -- The Olive Branch Fund: A Thisbe and Noah Scott Legacy, an organization dedicated to combating pediatric motor neuron diseases, today announced its first funding award to Kevin Eggan, Ph.D., Associate Professor of Stem Cell and Regenerative Biology at Harvard University.  The award will support Dr. Eggan's ongoing research investigating the neuromuscular system and the diseases that affect it.  Dr. Eggan is a leading researcher in motor neuron disease. He received the MacArthur Fellowship in 2006 and received the Presidential Early Career Award for Science and Engineering from President George Bush in 2008.

"This initial grant to Dr. Eggan is an incredibly exciting milestone for us as we begin to invest the funds we have raised to support the mission of The Olive Branch Fund and to advance groundbreaking research in the fight against motor neuron disease.  We are pleased this award will support Dr. Eggan's important research while also providing clues into the mechanisms of Brown-Vialetto-Van Laere syndrome," said Laurian Scott, Co-Founder of The Olive Branch Fund.  Brown-Vialetto-Van Laere syndrome is a rare, progressive, neurodegenerative motor neuron disorder that specifically includes palsies (paralysis) of the cranial nerves, and is sometimes referred to as "bulbar palsy."  Throughout the past century, few cases of Brown-Vialetto-Van Laere have been reported in the literature, but those numbers are growing.

The Olive Branch Fund: A Thisbe and Noah Scott Legacy was formed in 2008 to promote research, awareness, and support for families of all pediatric motor neuron diseases in memory of Laurian and John Scott's two children, Noah, who passed away at 19 months, and Thisbe, who passed away just before her third birthday.  Six cities nationwide, including Nashville, Memphis, Richmond, and Phoenix, have held fundraisers for The Olive Branch Fund, raising over $500,000.  These fundraisers are titled "A Mighty Voice" and aid The Olive Branch Fund in carrying out its mission worldwide.

The Olive Branch Fund: A Thisbe and Noah Scott Legacy is a component fund of the Community Foundation of Middle Tennessee.  For more information, please visit www.theolivebranchfund.org.


'/>"/>
SOURCE The Olive Branch Fund
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. New antioxidant compounds have been identified in foods such as olive oil, honey and nuts
2. New antioxidant compounds have been identified in foods such as olive oil, honey and nuts
3. Powered by olive stones? Turning waste stones into fuel
4. Rcadia COR Analyzer System Safely Rules Out Coronary Artery Disease in Main Coronary Arteries and Branch Vessels
5. Edwin Rivera-Martinez, Former Chief of the FDA’s International Compliance Branch, Joins PAREXEL Consulting Strategic Compliance Team
6. Pharma ChemOutsourcing Unveils 100 Pharma & Biotech Speaker Faculty for 2009 Conference September 14-16 in Long Branch, NJ
7. Stunning Attendance for ChemOutsourcing Show on September 8-9 in Long Branch, NJ
8. Verenium Announces Signing of Lease for New Office and Lab Space
9. Celladon Corporation Announces Publication of Advanced Heart Failure Clinical Trial Results With MYDICAR® Enzyme Replacement Therapy in the Journal Circulation
10. Scotland Announces Goal to Double Life Sciences Contribution to Scottish Economy by 2020 at BIO
11. PharmacoFore, Inc. Announces Appointment of Chief Medical Officer and Vice President of Intellectual Property
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... , March 24, 2017 Agenus Inc. (NASDAQ: ... checkpoint antibodies and cancer vaccines, today announced participation at ... th  Annual William Blair and Maidstone Life Sciences conference ... Center in New York, NY . ... March 29 at 9:40 am: Robert B. Stein ...
(Date:3/23/2017)... ... 23, 2017 , ... Lajollacooks4u is proud to announce it has become the premiere team-building cooking ... for companies around the world, such as Illumina, HP and Qualcomm, and is ranked #1 ... increasing popularity is due to its new team building format, a way for teams to ...
(Date:3/23/2017)...  Northwest Biotherapeutics (OTCQB: NWBO) (NW Bio), a ... solid tumor cancers, today announced that yesterday it ... last Friday, March 17, 2017. ... totaling 28,843,692 shares, comprised of 18,843,692 common shares ... Class C Warrants pre-funded at the closing at ...
(Date:3/23/2017)...  GlobeImmune, Inc. today announced it has entered into ... shares of its common stock to NantCell, Inc., a ... the sale of its common stock, NantCell has agreed ... GlobeImmune 200,000 shares, an estimated $2.0 million in value, ... pleased to enter into this strategic agreement with NantCell," ...
Breaking Biology Technology:
(Date:3/2/2017)... Summary This report provides all ... and its partnering interests and activities since 2010. ... The Partnering Deals and Alliance since 2010 report provides ... of the world,s leading life sciences companies. ... ensure inclusion of the most up to date deal ...
(Date:2/28/2017)... , February 28, 2017 News solutions ... ... Amsterdam from 14 to 16 March, Materna will ... and show how seamless travel is a real benefit for passengers. ... added biometrics to their passenger touch point solutions to take passengers ...
(Date:2/22/2017)... 22, 2017 With the biometrics market ... identifies four technologies that innovative and agile startups ... share in the changing competitive landscape: multifactor authentication ...   "Companies can no longer afford ... says Dimitrios Pavlakis , Industry Analyst at ...
Breaking Biology News(10 mins):